Perimenopause + menopause calculator.
An interactive map of where you sit in the transition — built from cycle pattern, symptom intensity, and the supportive systems around you. Educational, source-grounded, and self-paced.
The calculators, sliders, biomarker visualizations, symptom tools, educational graphs, charts, and interactive content provided on this website are intended for general educational and informational purposes only.
These tools are not intended to diagnose, treat, cure, or prevent any disease or medical condition, and they do not constitute medical advice, clinical recommendations, or the practice of medicine.
Results generated by these educational tools are estimates and visual educational references only. Individual health needs, laboratory interpretation, treatment decisions, and medical recommendations require evaluation by a licensed healthcare professional familiar with your personal medical history, symptoms, medications, and clinical status.
Always consult your physician, primary care provider, or qualified healthcare professional before making decisions related to medications, hormones, supplements, exercise, nutrition, or treatment plans.
Do not disregard professional medical advice or delay seeking care because of information provided through this website or its educational tools.
If you believe you may be experiencing a medical emergency, call 911 immediately or seek emergency medical attention.
Use of this website, including its calculators, educational tools, visualizations, and interactive systems, does not establish a provider-patient relationship.
The content on this website is designed to support health education and informed discussions with licensed healthcare professionals only.
Tell the calculator what's true right now.
Tap any of the adjacent domains that genuinely feel supported right now.
Updates as you adjust the inputs. Educational orientation — not a diagnosis.
Estradiol becomes more variable — often higher peaks and lower troughs — while progesterone trends downward. The reference frames this as a fluctuation window, not a deficiency window.
Select intensity on any symptom above to surface a personal cluster.
- Estradiol (E2)
- Progesterone
- FSH (Follicle-Stimulating Hormone)
- Testosterone (Women)
- Thyroid (Free T3 / TSH)
- DHEA-S
- Cortisol
- Ferritin (Iron Stores)
Standard panel underneath: Hormones · Lipids · CBC · CMP. Provider-reviewed.
Adjacent systems share the load with the hormonal map — sleep, training, nutrition, stress, daylight, and stimulant context.
Start your Health Intelligence pathway.
The menopausal transition is provider-reviewed, biomarker-grounded, and longitudinal. Route into care in under two minutes.
Common assumptions, gently corrected.
Perimenopause is its own distinct window — characterized by hormonal variability, not deficiency. The reference treats it as a phase that often warrants its own framing and evaluation.
Hormonal shifts — particularly progesterone — often precede visible cycle changes. Sleep, mood, and PMS pattern can shift while cycles still appear regular.
Vasomotor symptoms commonly appear in perimenopause — sometimes years before the final cycle. They are a signal of estradiol variability, not a marker of menopause itself.
Some symptoms settle; others persist for years and shape long-term health. The reference treats the transition as a window where context, biomarkers, and provider conversation are particularly useful.
The reference treats hormone optimization as a provider-managed conversation that weighs personal context and biomarker baseline. Safety lives in the evaluation, not in blanket avoidance.
What the reference actually says.
- The reference frames perimenopause as the variable window leading up to the final menstrual period — often beginning in the 40s, sometimes earlier. The clearest marker is cycle variability, not a single age.
- Duration is highly individual — commonly several years. The transition is best understood as a window of hormonal variability rather than a fixed timeline.
- Menopause is a single point — 12 months after the final menstrual period. The years before are perimenopause; the years after are postmenopause.
- Yes. The reference treats baseline biomarkers — captured before significant variability begins — as some of the most useful long-arc context for later optimization conversations.
- The reference frames hormone optimization as a provider-managed conversation that weighs personal context, baseline biomarkers, and ongoing recalibration. Stage of transition is one input among many.
- The reference distinguishes the conventional reference range ('normal') from the upper portion associated with documented benefits ('optimal'). Symptoms can persist within normal ranges when values sit below the optimal band.
- Yes. oMeds care is synchronous — live video with a licensed provider in your state. Hormone optimization is provider-managed end-to-end.
- For hormone optimization pathways, a baseline biomarker panel is required before initiation and on a recalibration cadence. The standard panel covers hormones, lipids, CBC, and CMP.